Freenome is a series c plus startup based in United States. 1 investor tracked.
Freenome is a startup founded in 2014 based in the United States. Brouky records 7 investors associated with the company.
Freenome develops AI-driven blood tests for early cancer detection by analyzing cell-free biomarkers to identify cancer in its early stages.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.